Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Zydus Lifesciences Ltd.

NSE: ZYDUSLIFE | BSE: 532321 | ISIN: INE010B01027 | Industry: Pharmaceuticals
| Mid-range Performer

957.6500 -16.75 (-1.72%)

NSE Jun 17, 2025 15:46 PM

27.69% Fall from 52W High

Volume: 1.6M

Zydus Lifesciences Ltd.

01 Dec 2023

957.65

-1.72%

Company Update

Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Zydus receives final approval from the USFDA for Ivabradine Tablets, 5 mg and 7.5 mg

More from Zydus Lifesciences Ltd.

Recommended

Market trades lower, CG Power bags a Rs 641 cr order from Power Grid for 765/400 kV transformers

Trendlyne Marketwatch | 17 Jun 2025, 03:28PM

Chart of the Week: FIIs raise bets in consumer-driven sectors over the year

The Baseline | 16 Jun 2025, 05:21PM

Earnings Call Transcript - Cadila Healthcare